CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Levonorgestrel

左炔诺孕酮 杂质对照品Levonorgestrel Impurities

EP37 个杂质条目37 impurity entries

本页汇总 左炔诺孕酮 的 37 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 37 impurity reference standards of Levonorgestrel with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 左炔诺孕酮(Levonorgestrel)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and optimization of stability-indicating method of ethinylestradiol, levonorgestrel, and their main impurities using quality by design approach
    Journal of pharmaceutical and biomedical analysis · 2023 · da Silva FA et al.  ·  PMID 36586384  ·  DOI
  2. 杂质研究Impurity studiesStability-indicating high-performance thin-layer chromatographic determination of levonorgestrel and ethinyloestradiol in bulk drug and in low-dosage oral contraceptives
    Analytica chimica acta · 2006 · Fakhari AR et al.  ·  PMID 17723483  ·  DOI
  3. 杂质研究Impurity studiesGenotoxic effects of combined multiple stressors on Gammarus locusta haemocytes: Interactions between temperature, pCO(2) and the synthetic progestin levonorgestrel
    Environmental pollution (Barking, Essex : 1987) · 2019 · Cruzeiro C et al.  ·  PMID 30504037  ·  DOI
  4. 分析方法Analytical MethodsRP-HPLC method validation for fast extraction and quantification of Levonorgestrel drug from silicone based intrauterine device intended for in-process and finished formulation
    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2021 · Veeran MG et al.  ·  PMID 33934266  ·  DOI
  5. 分析方法Analytical MethodsDevelopment, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2018 · Cirrincione LR et al.  ·  PMID 29579732  ·  DOI

左炔诺孕酮 —— 原料药与杂质对照品Levonorgestrel — drug substance & impurities

共 38 个条目(含原料药本体)38 items incl. the drug substance
Levonorgestrel structure
EP原料药 APIAPI
左炔诺孕酮Levonorgestrel
Levonorgestrel
CAS No.797-63-7
Chemical FormulaC21H28O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 1 (Levonorgestrel EP Impurity A) structure
EPA
左炔诺孕酮杂质1 (左炔诺孕酮EP杂质A)Levonorgestrel Impurity 1 (Levonorgestrel EP Impurity A)
Levonorgestrel Impurity 1 (Levonorgestrel EP Impurity A)
CAS No.1260525-53-8
Chemical FormulaC21H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 2 (Levonorgestrel EP Impurity B) structure
EPB
左炔诺孕酮杂质2 (左炔诺孕酮EP杂质B)Levonorgestrel Impurity 2 (Levonorgestrel EP Impurity B)
Levonorgestrel Impurity 2 (Levonorgestrel EP Impurity B)
CAS No.19914-67-1
Chemical FormulaC21H28O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 3(Levonorgestrel EP Impurity C) structure
EPC
左炔诺孕酮杂质3(左炔诺孕酮EP杂质C)Levonorgestrel Impurity 3(Levonorgestrel EP Impurity C)
Levonorgestrel Impurity 3(Levonorgestrel EP Impurity C)
CAS No.1337972-89-0
Chemical FormulaC23H28O
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 4(Levonorgestrel EP Impurity D) structure
EPD
左炔诺孕酮杂质4(左炔诺孕酮EP杂质D)Levonorgestrel Impurity 4(Levonorgestrel EP Impurity D)
Levonorgestrel Impurity 4(Levonorgestrel EP Impurity D)
CAS No.32419-58-2
Chemical FormulaC21H30O
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 7(Levonorgestrel EP Impurity G) structure
EPG
左炔诺孕酮杂质7(左炔诺孕酮EP杂质G)Levonorgestrel Impurity 7(Levonorgestrel EP Impurity G)
Levonorgestrel Impurity 7(Levonorgestrel EP Impurity G)
CAS No.87585-03-3
Chemical FormulaC21H28O3
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 8(Levonorgestrel EP Impurity H) structure
EPH
左炔诺孕酮杂质8(左炔诺孕酮EP杂质H)Levonorgestrel Impurity 8(Levonorgestrel EP Impurity H)
Levonorgestrel Impurity 8(Levonorgestrel EP Impurity H)
CAS No.55555-97-0
Chemical FormulaC21H28O3
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 9(Levonorgestrel EP Impurity I) structure
EPI
左炔诺孕酮杂质9(左炔诺孕酮EP杂质I)Levonorgestrel Impurity 9(Levonorgestrel EP Impurity I)
Levonorgestrel Impurity 9(Levonorgestrel EP Impurity I)
CAS No.21508-50-9
Chemical FormulaC21H28O3
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 10(Levonorgestrel EP Impurity J) structure
EPJ
左炔诺孕酮杂质10(左炔诺孕酮EP杂质J)Levonorgestrel Impurity 10(Levonorgestrel EP Impurity J)
Levonorgestrel Impurity 10(Levonorgestrel EP Impurity J)
CAS No.1175109-63-3
Chemical FormulaC21H26O3
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 11(Levonorgestrel EP Impurity K) structure
EPK
左炔诺孕酮杂质11(左炔诺孕酮EP杂质K)Levonorgestrel Impurity 11(Levonorgestrel EP Impurity K)
Levonorgestrel Impurity 11(Levonorgestrel EP Impurity K)
CAS No.793-55-5
Chemical FormulaC19H28O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 12(Levonorgestrel EP Impurity L) structure
EPL
左炔诺孕酮杂质12(左炔诺孕酮EP杂质L)Levonorgestrel Impurity 12(Levonorgestrel EP Impurity L)
Levonorgestrel Impurity 12(Levonorgestrel EP Impurity L)
CAS No.21800-83-9
Chemical FormulaC19H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 13(Levonorgestrel EP Impurity M) structure
EPM
左炔诺孕酮杂质13(左炔诺孕酮EP杂质M)Levonorgestrel Impurity 13(Levonorgestrel EP Impurity M)
Levonorgestrel Impurity 13(Levonorgestrel EP Impurity M)
CAS No.51087-61-7
Chemical FormulaC21H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 14(Levonorgestrel EP Impurity N) structure
EPN
左炔诺孕酮杂质14(左炔诺孕酮EP杂质N)Levonorgestrel Impurity 14(Levonorgestrel EP Impurity N)
Levonorgestrel Impurity 14(Levonorgestrel EP Impurity N)
CAS No.4222-96-2
Chemical FormulaC19H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 15(Levonorgestrel EP Impurity O) structure
EPO
左炔诺孕酮杂质15(左炔诺孕酮EP杂质O)Levonorgestrel Impurity 15(Levonorgestrel EP Impurity O)
Levonorgestrel Impurity 15(Levonorgestrel EP Impurity O)
CAS No.155683-60-6
Chemical FormulaC22H32O3
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 16(Levonorgestrel EP Impurity P) structure
EPP
左炔诺孕酮杂质16(左炔诺孕酮EP杂质P)Levonorgestrel Impurity 16(Levonorgestrel EP Impurity P)
Levonorgestrel Impurity 16(Levonorgestrel EP Impurity P)
CAS No.100021-05-4
Chemical FormulaC21H28O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel EP Impurity P structure
EPP
左炔诺孕酮EP杂质PLevonorgestrel EP Impurity P
Levonorgestrel EP Impurity P
CAS No.10021-05-4
Chemical FormulaC21H28O2
Purity>95%现货In stock
10mg25mg50mg100mg
Levonorgestrel Impurity 17 (Levonorgestrel EP Impurity Q) structure
EPQ
左炔诺孕酮杂质17 (左炔诺孕酮EP杂质Q)Levonorgestrel Impurity 17 (Levonorgestrel EP Impurity Q)
Levonorgestrel Impurity 17 (Levonorgestrel EP Impurity Q)
CAS No.14507-49-4
Chemical FormulaC20H30O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 18(Levonorgestrel EP Impurity R) structure
EPR
左炔诺孕酮杂质18(左炔诺孕酮EP杂质R)Levonorgestrel Impurity 18(Levonorgestrel EP Impurity R)
Levonorgestrel Impurity 18(Levonorgestrel EP Impurity R)
CAS No.2322-77-2
Chemical FormulaC20H28O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 19 (Levonorgestrel EP Impurity S) structure
EPS
左炔诺孕酮杂质19 (左炔诺孕酮EP杂质S)Levonorgestrel Impurity 19 (Levonorgestrel EP Impurity S)
Levonorgestrel Impurity 19 (Levonorgestrel EP Impurity S)
CAS No.176254-10-7
Chemical FormulaC22H30O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 20 (Levonorgestrel EP Impurity T) structure
EPT
左炔诺孕酮杂质20 (左炔诺孕酮EP杂质T)Levonorgestrel Impurity 20 (Levonorgestrel EP Impurity T)
Levonorgestrel Impurity 20 (Levonorgestrel EP Impurity T)
CAS No.14507-51-8
Chemical FormulaC22H30O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 21(Levonorgestrel EP Impurity U) structure
EPU
左炔诺孕酮杂质21(左炔诺孕酮EP杂质U)Levonorgestrel Impurity 21(Levonorgestrel EP Impurity U)
Levonorgestrel Impurity 21(Levonorgestrel EP Impurity U)
CAS No.68-22-4
Chemical FormulaC20H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 22(Levonorgestrel EP Impurity V) structure
EPV
左炔诺孕酮杂质22(左炔诺孕酮EP杂质V)Levonorgestrel Impurity 22(Levonorgestrel EP Impurity V)
Levonorgestrel Impurity 22(Levonorgestrel EP Impurity V)
CAS No.14009-70-2
Chemical FormulaC22H28O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 23(Levonorgestrel EP Impurity W) structure
EPW
左炔诺孕酮杂质23(左炔诺孕酮EP杂质W)Levonorgestrel Impurity 23(Levonorgestrel EP Impurity W)
Levonorgestrel Impurity 23(Levonorgestrel EP Impurity W)
CAS No.155683-59-3
Chemical FormulaC21H24O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 24 structure
24
左炔诺孕酮杂质24Levonorgestrel Impurity 24
Levonorgestrel Impurity 24
CAS No.14507-47-2
Chemical FormulaC22H28O3
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 25 structure
25
左炔诺孕酮杂质25Levonorgestrel Impurity 25
Levonorgestrel Impurity 25
CAS No.20402-62-4
Chemical FormulaC21H28O3
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 27 structure
27
左炔诺孕酮杂质27Levonorgestrel Impurity 27
Levonorgestrel Impurity 27
CAS No.797-64-8
Chemical FormulaC21H28O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 28 structure
28
左炔诺孕酮杂质28Levonorgestrel Impurity 28
Levonorgestrel Impurity 28
CAS No.799-43-9
Chemical FormulaC22H30O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 29 structure
29
左炔诺孕酮杂质29Levonorgestrel Impurity 29
Levonorgestrel Impurity 29
CAS No.78088-19-4
Chemical FormulaC21H30O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 30 structure
30
左炔诺孕酮杂质30Levonorgestrel Impurity 30
Levonorgestrel Impurity 30
CAS No.19913-28-1
Chemical FormulaC25H34O4
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 31 structure
31
左炔诺孕酮杂质31Levonorgestrel Impurity 31
Levonorgestrel Impurity 31
CAS No.117635-12-8
Chemical FormulaC25H34O6
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 32 structure
32
左炔诺孕酮杂质32Levonorgestrel Impurity 32
Levonorgestrel Impurity 32
CAS No.1458616-80-2
Chemical FormulaC20H26O3
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 36 structure
36
左炔诺孕酮杂质36Levonorgestrel Impurity 36
Levonorgestrel Impurity 36
CAS No.1038-28-4
Chemical FormulaC20H30O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 37 structure
37
左炔诺孕酮杂质37Levonorgestrel Impurity 37
Levonorgestrel Impurity 37
CAS No.62298-52-6
Chemical FormulaC20H24O3
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 38 structure
38
左炔诺孕酮杂质38Levonorgestrel Impurity 38
Levonorgestrel Impurity 38
CAS No.51773-49-0
Chemical FormulaC20H26O3
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 39 structure
39
左炔诺孕酮杂质39Levonorgestrel Impurity 39
Levonorgestrel Impurity 39
CAS No.7443-72-3
Chemical FormulaC20H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 41 structure
41
左炔诺孕酮杂质41Levonorgestrel Impurity 41
Levonorgestrel Impurity 41
CAS No.93798-38-0
Chemical FormulaC21H24O2
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 44 structure
44
左炔诺孕酮杂质44Levonorgestrel Impurity 44
Levonorgestrel Impurity 44
CAS No.38165-80-9
Chemical FormulaC21H24O3
Purity>95%询价On request
10mg25mg50mg100mg
Levonorgestrel Impurity 46 structure
46
左炔诺孕酮杂质46Levonorgestrel Impurity 46
Levonorgestrel Impurity 46
CAS No.300542-76-1
Chemical FormulaC19H26O2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

左炔诺孕酮 —— 研究文献与合成路线Levonorgestrel — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 左炔诺孕酮 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Levonorgestrel. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development and optimization of stability-indicating method of ethinylestradiol, levonorgestrel, and their main impurities using quality by design approach
    da Silva FA, Lourenço FR, Calixto LA · Journal of pharmaceutical and biomedical analysis · 2023 · 被引 1cited 1
  2. Prediction of internal standards in reversed-phase liquid chromatography. II. Selectivity optimization and internal standard prediction for the quantitation of estradiol and levonorgestrel in a transdermal drug delivery formulation based on the linear solvation energy relationships
    Li J, Shah DS · Journal of chromatography. A · 2002 · 被引 7cited 7
  3. RP-HPLC method validation for fast extraction and quantification of Levonorgestrel drug from silicone based intrauterine device intended for in-process and finished formulation
    Veeran MG, C K, B B, et al. · Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2021 · 被引 1cited 1

合成与制备工艺专利Synthesis & process patents

  1. Levonorgestrel drop pills and preparation method thereof
    JINSHENG HOU, LI WANG · 公开号 CN101288660CN101288660 · 2008

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

左炔诺孕酮 杂质谱研究要点Levonorgestrel — impurity profiling notes

下面这些是拿到 左炔诺孕酮 的 38 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 38 impurity entries for Levonorgestrel, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances